Dimethyl α-ketoglutarate inhibits maladaptive autophagy in pressure overload-induced cardiomyopathy

Guillermo Mariño, Federico Pietrocola, Yongli Kong, Tobias Eisenberg, Joseph A Hill, Frank Madeo, Guido Kroemer

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

It has been a longstanding problem to identify specific and efficient pharmacological modulators of autophagy. Recently, we found that depletion of acetyl-coenzyme A (AcCoA) induced autophagic flux, while manipulations designed to increase cytosolic AcCoA efficiently inhibited autophagy. Thus, the cell permeant ester dimethyl α-ketoglutarate (DMKG) increased the cytosolic concentration of α-ketoglutarate, which was converted into AcCoA through a pathway relying on either of the 2 isocitrate dehydrogenase isoforms (IDH1 or IDH2), as well as on ACLY (ATP citrate lyase). DMKG inhibited autophagy in an IDH1-, IDH2- and ACLY-dependent fashion in vitro, in cultured human cells. Moreover, DMKG efficiently prevented autophagy induced by starvation in vivo, in mice. Autophagy plays a maladaptive role in the dilated cardiomyopathy induced by pressure overload, meaning that genetic inhibition of autophagy by heterozygous knockout of Becn1 suppresses the pathological remodeling of heart muscle responding to hemodynamic stress. Repeated administration of DMKG prevents autophagy in heart muscle responding to thoracic aortic constriction (TAC) and simultaneously abolishes all pathological and functional correlates of dilated cardiomyopathy: hypertrophy of cardiomyocytes, fibrosis, dilation of the left ventricle, and reduced contractile performance. These findings indicate that DMKG may be used for therapeutic autophagy inhibition.

Original languageEnglish (US)
Pages (from-to)930-932
Number of pages3
JournalAutophagy
Volume10
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Autophagy
Cardiomyopathies
Pressure
Acetyl Coenzyme A
ATP Citrate (pro-S)-Lyase
Dilated Cardiomyopathy
Myocardium
Isocitrate Dehydrogenase
Starvation
Cardiac Myocytes
Constriction
Hypertrophy
Heart Ventricles
Dilatation
Cultured Cells
Protein Isoforms
Esters
Fibrosis
Thorax
Hemodynamics

Keywords

  • Acetyl-coenzyme A
  • Dilated cardiopathy
  • Macroautophagy

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Mariño, G., Pietrocola, F., Kong, Y., Eisenberg, T., Hill, J. A., Madeo, F., & Kroemer, G. (2014). Dimethyl α-ketoglutarate inhibits maladaptive autophagy in pressure overload-induced cardiomyopathy. Autophagy, 10(5), 930-932. https://doi.org/10.4161/auto.28235

Dimethyl α-ketoglutarate inhibits maladaptive autophagy in pressure overload-induced cardiomyopathy. / Mariño, Guillermo; Pietrocola, Federico; Kong, Yongli; Eisenberg, Tobias; Hill, Joseph A; Madeo, Frank; Kroemer, Guido.

In: Autophagy, Vol. 10, No. 5, 2014, p. 930-932.

Research output: Contribution to journalArticle

Mariño, G, Pietrocola, F, Kong, Y, Eisenberg, T, Hill, JA, Madeo, F & Kroemer, G 2014, 'Dimethyl α-ketoglutarate inhibits maladaptive autophagy in pressure overload-induced cardiomyopathy', Autophagy, vol. 10, no. 5, pp. 930-932. https://doi.org/10.4161/auto.28235
Mariño, Guillermo ; Pietrocola, Federico ; Kong, Yongli ; Eisenberg, Tobias ; Hill, Joseph A ; Madeo, Frank ; Kroemer, Guido. / Dimethyl α-ketoglutarate inhibits maladaptive autophagy in pressure overload-induced cardiomyopathy. In: Autophagy. 2014 ; Vol. 10, No. 5. pp. 930-932.
@article{fd53abc87c1943358f3914685a674e59,
title = "Dimethyl α-ketoglutarate inhibits maladaptive autophagy in pressure overload-induced cardiomyopathy",
abstract = "It has been a longstanding problem to identify specific and efficient pharmacological modulators of autophagy. Recently, we found that depletion of acetyl-coenzyme A (AcCoA) induced autophagic flux, while manipulations designed to increase cytosolic AcCoA efficiently inhibited autophagy. Thus, the cell permeant ester dimethyl α-ketoglutarate (DMKG) increased the cytosolic concentration of α-ketoglutarate, which was converted into AcCoA through a pathway relying on either of the 2 isocitrate dehydrogenase isoforms (IDH1 or IDH2), as well as on ACLY (ATP citrate lyase). DMKG inhibited autophagy in an IDH1-, IDH2- and ACLY-dependent fashion in vitro, in cultured human cells. Moreover, DMKG efficiently prevented autophagy induced by starvation in vivo, in mice. Autophagy plays a maladaptive role in the dilated cardiomyopathy induced by pressure overload, meaning that genetic inhibition of autophagy by heterozygous knockout of Becn1 suppresses the pathological remodeling of heart muscle responding to hemodynamic stress. Repeated administration of DMKG prevents autophagy in heart muscle responding to thoracic aortic constriction (TAC) and simultaneously abolishes all pathological and functional correlates of dilated cardiomyopathy: hypertrophy of cardiomyocytes, fibrosis, dilation of the left ventricle, and reduced contractile performance. These findings indicate that DMKG may be used for therapeutic autophagy inhibition.",
keywords = "Acetyl-coenzyme A, Dilated cardiopathy, Macroautophagy",
author = "Guillermo Mari{\~n}o and Federico Pietrocola and Yongli Kong and Tobias Eisenberg and Hill, {Joseph A} and Frank Madeo and Guido Kroemer",
year = "2014",
doi = "10.4161/auto.28235",
language = "English (US)",
volume = "10",
pages = "930--932",
journal = "Autophagy",
issn = "1554-8627",
publisher = "Landes Bioscience",
number = "5",

}

TY - JOUR

T1 - Dimethyl α-ketoglutarate inhibits maladaptive autophagy in pressure overload-induced cardiomyopathy

AU - Mariño, Guillermo

AU - Pietrocola, Federico

AU - Kong, Yongli

AU - Eisenberg, Tobias

AU - Hill, Joseph A

AU - Madeo, Frank

AU - Kroemer, Guido

PY - 2014

Y1 - 2014

N2 - It has been a longstanding problem to identify specific and efficient pharmacological modulators of autophagy. Recently, we found that depletion of acetyl-coenzyme A (AcCoA) induced autophagic flux, while manipulations designed to increase cytosolic AcCoA efficiently inhibited autophagy. Thus, the cell permeant ester dimethyl α-ketoglutarate (DMKG) increased the cytosolic concentration of α-ketoglutarate, which was converted into AcCoA through a pathway relying on either of the 2 isocitrate dehydrogenase isoforms (IDH1 or IDH2), as well as on ACLY (ATP citrate lyase). DMKG inhibited autophagy in an IDH1-, IDH2- and ACLY-dependent fashion in vitro, in cultured human cells. Moreover, DMKG efficiently prevented autophagy induced by starvation in vivo, in mice. Autophagy plays a maladaptive role in the dilated cardiomyopathy induced by pressure overload, meaning that genetic inhibition of autophagy by heterozygous knockout of Becn1 suppresses the pathological remodeling of heart muscle responding to hemodynamic stress. Repeated administration of DMKG prevents autophagy in heart muscle responding to thoracic aortic constriction (TAC) and simultaneously abolishes all pathological and functional correlates of dilated cardiomyopathy: hypertrophy of cardiomyocytes, fibrosis, dilation of the left ventricle, and reduced contractile performance. These findings indicate that DMKG may be used for therapeutic autophagy inhibition.

AB - It has been a longstanding problem to identify specific and efficient pharmacological modulators of autophagy. Recently, we found that depletion of acetyl-coenzyme A (AcCoA) induced autophagic flux, while manipulations designed to increase cytosolic AcCoA efficiently inhibited autophagy. Thus, the cell permeant ester dimethyl α-ketoglutarate (DMKG) increased the cytosolic concentration of α-ketoglutarate, which was converted into AcCoA through a pathway relying on either of the 2 isocitrate dehydrogenase isoforms (IDH1 or IDH2), as well as on ACLY (ATP citrate lyase). DMKG inhibited autophagy in an IDH1-, IDH2- and ACLY-dependent fashion in vitro, in cultured human cells. Moreover, DMKG efficiently prevented autophagy induced by starvation in vivo, in mice. Autophagy plays a maladaptive role in the dilated cardiomyopathy induced by pressure overload, meaning that genetic inhibition of autophagy by heterozygous knockout of Becn1 suppresses the pathological remodeling of heart muscle responding to hemodynamic stress. Repeated administration of DMKG prevents autophagy in heart muscle responding to thoracic aortic constriction (TAC) and simultaneously abolishes all pathological and functional correlates of dilated cardiomyopathy: hypertrophy of cardiomyocytes, fibrosis, dilation of the left ventricle, and reduced contractile performance. These findings indicate that DMKG may be used for therapeutic autophagy inhibition.

KW - Acetyl-coenzyme A

KW - Dilated cardiopathy

KW - Macroautophagy

UR - http://www.scopus.com/inward/record.url?scp=84899738247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899738247&partnerID=8YFLogxK

U2 - 10.4161/auto.28235

DO - 10.4161/auto.28235

M3 - Article

C2 - 24675140

AN - SCOPUS:84899738247

VL - 10

SP - 930

EP - 932

JO - Autophagy

JF - Autophagy

SN - 1554-8627

IS - 5

ER -